×
Advocating for and Supporting the Development of Biotechnologies Focused on Ending Age-Related Diseases
News
Latest News
Cancer Drug Delays Cellular Senescence
Posted in: News
LifeXtenShow
LifeXtenShow – Loss of Proteostasis
Posted in: LifeXtenShow, News
LEAF Activities
Bringing You the Latest Anti-Aging and Biotechnology News
Recent Comments
- on Accelerating Rejuvenation Research Through Public Advocacy
- on Fisetin May be a Low-Hanging Fruit for Aging
- on Cancer Drug Delays Cellular Senescence
- on Accelerating Rejuvenation Research Through Public Advocacy
- on Accelerating Rejuvenation Research Through Public Advocacy
- on Accelerating Rejuvenation Research Through Public Advocacy
- on Human Safety Trial of NMN Concludes
- on David Sinclair on NMN and Epigenetics
- on Dr. Greg Fahy – Rejuvenating the Thymus to Prevent Age-related Diseases
- on David Sinclair on NMN and Epigenetics
Bringing You the Information You Need to Know About Rejuvenation Biotechnology
EDITOR'S PICKS
The 9 Things That Are Slowly Killing You!
We take a look at the hallmarks of aging that lead to age-related ill health.
Results Show Human Aging Can Be Reversed
A small clinical trial, which was conducted by a team of researchers led by Dr. Greg Fahy, has shown for the first time in humans that reversing biological age may be possible.
How We Treat Aging is Going to Change in the Future
Dr. David Sinclair, a Professor of Genetics at Harvard Medical School, is one of the most well-known researchers in the field of rejuvenation well known for his work with NAD+ and aging.
Stay in the know
Join our newsletter and be the first to know what’s new in anti-aging research.
Popularizing Rejuvenation Biotechnology Through Public Engagement
OUR SHOWS
LifeXtenShow
LifeXtenShow – Loss of Proteostasis
On this informative episode of X10, Giuliano explains proteins and how they misfold, causing the hallmark of agi...Posted in: LifeXtenShow, News
Webinars
SENS MitoMouse Q&A Webinar Video
On Friday, October 25, we hosted a Q&A webinar with the team behind MitoMouse, the second MitoSENS program t...
Journal Club
Journal Club January – Results From a Human Trial f...
The January edition of Journal Club, hosted by Dr. Oliver Medvedik, took a look at the results of a recent human...Posted in: Journal club, News
The Rejuvenation Roundup Podcast
We collaborate with Ryan O’Shea from Future Grind and he presents the Rejuvenation Roundup Podcast, a monthly digest of the latest rejuvenation biotechnology news.
How to Cure Aging – During Your Lifetime?
We collaborate with popular Youtube channels to produce fun and educational shows about aging research. This video was made in collaboration with popular science channel – Kurzgesagt and has been seen by over 5 million people to date.
Supporting Research and Investment in Anti-Aging Therapeutics
CROWDFUNDED PROJECTS
Projects Funded on Lifespan.io
To date, we have raised over $360,000 for research since we launched our aging research crowdfunding platform – Lifespan.io.
We have helped the David Sinclair Lab at Harvard University to raise funding for the NAD+ Mouse project, a project that explores the metabolic drivers of aging and could have ramifications for human aging and health in the near future.
The SENS Research Foundation has successfully funded three projects on Lifespan.io and as a result is pioneering new approaches to treating mitochondria disorders and new ways to combat cancer.
Get the AgeMeter
A functional aging diagnostic system that was developed thanks to the support of the community. This unit allows you to measure how well you are aging using a series of scientifically supported biomarkers of aging that measure your level of function.
Get the MouseAge App
Thanks to the support of the community this cruelty free app allows researchers to estimate the age of lab mice using the power of deep learning without the need for invasive tests.
MitoSENS Published in Oxford Journal
Thanks to the support of the community the MitoSENS campaign funded on Lifespan.io has published successful results for their mitochondrial repair approach. This is the first demonstration that creating copies of mitochondrial genes in the cell nucleus may be a potential way to address mitochondrial DNA damage which is a root cause of various age-related diseases and other conditions.
SUPPORTING INVESTMENT
The Longevity Investor Network is a LEAF initiative to bring investors and promising, aging-focused biotech startups together. The network is organized by LEAF board members and meets once a month to listen to presentation pitches from new companies seeking funding.
